AlphaCentric Advisors »

Newamsterdam Pharma Co Nv shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $469k 15k 32.01
2025-12-31 $482k 14k 35.08

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Astrazeneca Ord (AZN)
Vertex Pharmaceuticals Incorporated (VRTX)
Euronet Worldwide (EEFT)
Invitation Homes (INVH)
Ionis Pharmaceuticals (IONS)
Insmed Com Par $.01 (INSM)
Incyte Corporation (INCY)
Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
AMREP Corporation (AXR)
Saul Centers (BFS)

View all positions for AlphaCentric Advisors

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Capital World Investors
RA Capital Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
FMR
Wellington Management Company
Deerfield Management Company
Viking Global Investors
Duquesne Family Office
Polar Capital Holdings
Jennison Associates
Medicxi Ventures Management
Henderson Group
Westfield Capital Management Company

View all funds holding Newamsterdam Pharma Co Nv